Tech Company Inital Public Offerings
Molecular Insight Pharmaceuticals IPO
Molecular Insight Pharmaceuticals, operating out of Cambridge, debuted as a public company on 2/5/2007.
Transaction Overview
Company Name
Announced On
2/5/2007
Transaction Type
IPO
Amount
$70,000,000
Proceeds Purpose
Proceeds are disclosed per the offering prospectus.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
160 Second Street
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Overview
Molecular Insight Pharmaceuticals is developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Scientific Officer
John Babich
VP - Manufacturing
Wendy Graham-Coco
VP - Regulatory Affairs
James Wachholz
Browse more venture capital transactions:
Prev: 2/5/2007: Eversync venture capital transaction
Next: 2/5/2007: Hanger Network venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs